What Morphle Labs does
Morphle Labs builds physical-AI hardware for histopathology, including RoboTome, described as the first robotic microtome of its kind, and MorphoLens, a whole-slide digital pathology scanner that uses AI-driven imaging to scan over 100 slides per hour. Founded in 2017, Morphle Labs says it operates with nearly 100 employees across Bengaluru and Boston and serves hospital pathology departments, research institutions and diagnostic labs; multiple Indian press outlets describe it as Bengaluru-headquartered.
Morphle Labs is a healthcare tool on Falcoscan. Robotic microtomes and AI slide-scanners automating cancer diagnostics. Falcoscan rates Morphle Labs with an Opportunity score of 84/100, a Saturation score of 11/100, and a Wrapper-risk score of 9/100. Market signal: rising. Morphle Labs is founded in 2017, currently at Series_a stage. Pricing: Paid.